These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 398636)

  • 21. Immunoreactive prolactin in breast milk and plasma of women with hyperprolactinemia, galactorrhea and menstrual dysfunction.
    Yuen BH
    Int J Fertil; 1986; 31(1):67-70. PubMed ID: 2908279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic and therapeutic modalities in women with galactorrhea.
    Turksoy RN; Farber M; Mitchell GW
    Obstet Gynecol; 1980 Sep; 56(3):323-9. PubMed ID: 6775255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Galactorrhea-amenorrhea and hyperprolactinemia associated with pituitary tumors of growth-hormone- and adrenocorticotropic-hormone-secreting cells. A report of two cases.
    Haney AF; McCarty KS; Hammond CB
    J Reprod Med; 1984 Dec; 29(12):883-7. PubMed ID: 6097688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of hypothalamo-hypophyseal-adrenal axis in the pathogenesis of arterial hypertension in patients with prolactinoma of the anterior lobe of the hypophysis].
    Mychka VB; Chazova IE; Dmitriev VV; Masenko VP
    Ter Arkh; 2000; 72(9):10-3. PubMed ID: 11076407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolactin secreting pituitary adenoma: a review and study of their implications for fertility in women.
    Fode NC; Laws ER; Abboud CF; Randall RV; Kempers RD
    J Neurosurg Nurs; 1980 Dec; 12(4):210-3. PubMed ID: 6906361
    [No Abstract]   [Full Text] [Related]  

  • 26. Syndrome of galactorrhea, amenorrhea, and obesity as possible indicators of prolactinoma: a case study approach.
    Shaw B; Creary L; Rao V
    J Natl Med Assoc; 1986 Dec; 78(12):1197-200. PubMed ID: 3806693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolactinomas: surgical therapy, indications and results.
    Rawe SE; Williamson HO; Levine JH; Phansey SA; Hungerford D; Adkins WY
    Surg Neurol; 1980 Sep; 14(3):161-7. PubMed ID: 7434180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hyperprolactinemia as a frequent cause of amenorrhea and galactorrhea].
    Rjosk HK; Fahlbusch R; von Werder K
    Med Klin; 1980 Aug; 75(17):609-12. PubMed ID: 6997715
    [No Abstract]   [Full Text] [Related]  

  • 29. [Human prolactin (author's transl)].
    von Werder K; Rjosk HK
    Klin Wochenschr; 1979 Jan; 57(1):1-12. PubMed ID: 366279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hyperprolactinemia in clinical practice and therapeutics].
    Linquette M; Fossati P
    Rev Prat; 1976 Jun; 26(35):2425-34. PubMed ID: 959740
    [No Abstract]   [Full Text] [Related]  

  • 31. Pituitary autonomy in hyperprolactinemic secondary amenorrhea: results of hypothalamic-pituitary testing.
    Healy DL; Pepperell RJ; Stockdale J; Bremner WJ; Burger HG
    J Clin Endocrinol Metab; 1977 May; 44(5):809-19. PubMed ID: 404308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The amenorrhea-galactorrhea syndrome. Clinical and therapeutic aspects of 5 treated cases].
    Nicoletti I; Filipponi P; Nunzi E; Angeletti G; Santeusanio F
    Minerva Med; 1980 Jan; 71(2):89-96. PubMed ID: 7188809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypothalamic-pituitary evaluation in patients with galactorrhea-amenorrhea and hyperprolactinemia.
    Badawy SZ; Nusbaum ML; Omar M
    Obstet Gynecol; 1980 Jan; 55(1):1-7. PubMed ID: 6243406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacodynamic metoclopramide (cerucal) test in differential diagnosis of hypoprolactinemic hypogonadism syndrome in women].
    Balabolkin MI; Gerasimov GA; Liubimov AV
    Akush Ginekol (Mosk); 1990 Feb; (2):54-7. PubMed ID: 2339765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bromocriptine treatment of hyperprolactinaemic hypogonadism.
    Thorner MO; Besser GM
    Acta Endocrinol Suppl (Copenh); 1978; 216():131-46. PubMed ID: 347858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pathophysiology of hyperprolactinemic states and the role of newer ergot compounds in their treatment.
    Frantz AG; Kleinberg DL
    Fed Proc; 1978 Jun; 37(8):2192-7. PubMed ID: 26606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amenorrhea-galactorrhea syndrome with craniopharyngioma.
    Nakasu Y; Nakasu S; Handa J; Takeuchi J
    Surg Neurol; 1980 Feb; 13(2):154-6. PubMed ID: 6101923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prolactin-secreting microadenoma in menopausal women].
    Barka I; Dendana E; Chikhrouhou N; Maroufi A; Kacem M; Chadli M; Ach K
    Pan Afr Med J; 2017; 27():177. PubMed ID: 28904704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two-step development of a pituitary adenoma: from hyperprolactinemic syndrome to Cushing's disease.
    Gheri RG; Boddi W; Ammannati F; Olivotto J; Nozzoli C; Franchi A; Bordi L; Luisi ML; Mennonna P
    J Endocrinol Invest; 1997 Apr; 20(4):240-4. PubMed ID: 9211134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Persisting suppression of hyperprolactinemia after bromcriptine withdrawal].
    Drobnjak P; Simunić V; Puharić I; Suchanek E
    Jugosl Ginekol Opstet; 1982; 22(1-2):31-4. PubMed ID: 7132424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.